Literature DB >> 31351884

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy.

Craig A Elmets1, Henry W Lim2, Benjamin Stoff3, Cody Connor1, Kelly M Cordoro4, Mark Lebwohl5, April W Armstrong6, Dawn M R Davis7, Boni E Elewski1, Joel M Gelfand8, Kenneth B Gordon9, Alice B Gottlieb10, Daniel H Kaplan11, Arthur Kavanaugh12, Matthew Kiselica13, Dario Kivelevitch14, Neil J Korman15, Daniela Kroshinsky16, Craig L Leonardi17, Jason Lichten13, Nehal N Mehta18, Amy S Paller19, Sylvia L Parra20, Arun L Pathy21, Elizabeth A Farley Prater22, Reena N Rupani5, Michael Siegel13, Bruce E Strober23, Emily B Wong24, Jashin J Wu25, Vidhya Hariharan26, Alan Menter14.   

Abstract

Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approximately 3.2% of the world's population. In this section of the guidelines of care for psoriasis, we will focus the discussion on ultraviolet (UV) light-based therapies, which include narrowband and broadband UVB, UVA in conjunction with photosensitizing agents, targeted UVB treatments such as with an excimer laser, and several other modalities and variations of these core phototherapies, including newer applications of pulsed dye lasers, intense pulse light, and light-emitting electrodes. We will provide an in-depth, evidence-based discussion of efficacy and safety for each treatment modality and provide recommendations and guidance for the use of these therapies alone or in conjunction with other topical and/or systemic psoriasis treatments.
Copyright © 2019 American Academy of Dermatology, Inc. All rights reserved.

Entities:  

Keywords:  Goeckerman; PUVA (topical; bath; climatotherapy; grenz ray; intense pulsed dye laser; narrowband ultraviolet light A (NB-UVA); narrowband ultraviolet light B (NB-UVB); oral); photochemotherapy; photodynamic therapy; phototherapy; psoralen ultraviolet light A; psoriasis; pulsed dye laser; visible light

Mesh:

Year:  2019        PMID: 31351884     DOI: 10.1016/j.jaad.2019.04.042

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  16 in total

1.  A retrospective review of phototherapy in children, at a tertiary paediatric dermatology unit.

Authors:  Ella Seccombe; Matthew David Wynne; Cornelius Clancy; Keith M Godfrey; Adam Fityan
Journal:  Photodermatol Photoimmunol Photomed       Date:  2020-10-04       Impact factor: 3.135

Review 2.  New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies.

Authors:  Di Yan; Andrew Blauvelt; Amit K Dey; Rachel S Golpanian; Samuel T Hwang; Nehal N Mehta; Bridget Myers; Zhen-Rui Shi; Gil Yosipovitch; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-04-19       Impact factor: 7.590

Review 3.  Non-Oncologic Applications of Nanomedicine-Based Phototherapy.

Authors:  Su Woong Yoo; Gyungseok Oh; Jin Chul Ahn; Euiheon Chung
Journal:  Biomedicines       Date:  2021-01-25

4.  Assessment of efficacy and safety of UV-based therapy for psoriasis: a network meta-analysis of randomized controlled trials.

Authors:  Yajia Li; Ziqin Cao; Jia Guo; Qiangxiang Li; Wu Zhu; Yehong Kuang; Xiang Chen
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

5.  Viewing Psoriasis as a Systemic Disease for Better Health Outcomes.

Authors:  George C Gondo; Samantha Koons; Claire Metcalf; Stacie J Bell; Nehal N Mehta
Journal:  JID Innov       Date:  2021-03-04

6.  Impact of Psoriatic Disease on Quality of Life: Interim Results of a Global Survey.

Authors:  April Armstrong; Barbra Bohannan; Sicily Mburu; Ivette Alarcon; Torben Kasparek; Jihen Toumi; Susan Frade; Silvia Fernandez Barrio; Matthias Augustin
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-14

Review 7.  Therapeutic challenges in managing pediatric psoriasis.

Authors:  Yamila Goenaga-Vázquez; Kyle C Lauck; Adelaide A Hebert
Journal:  Int J Womens Dermatol       Date:  2020-10-10

Review 8.  Chronic Kidney Disease-Associated Itch (CKD-aI) in Children-A Narrative Review.

Authors:  Radomir Reszke; Katarzyna Kiliś-Pstrusińska; Jacek C Szepietowski
Journal:  Toxins (Basel)       Date:  2021-06-29       Impact factor: 4.546

9.  Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document.

Authors:  Isabel Belinchón Romero; Esteban Dauden; Carlos Ferrándiz Foraster; Álvaro González-Cantero; Jose Manuel Carrascosa Carrillo
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

10.  National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.

Authors:  Joel M Gelfand; April W Armstrong; Stacie Bell; George L Anesi; Andrew Blauvelt; Cassandra Calabrese; Erica D Dommasch; Steve R Feldman; Dafna Gladman; Leon Kircik; Mark Lebwohl; Vincent Lo Re; George Martin; Joseph F Merola; Jose U Scher; Sergio Schwartzman; James R Treat; Abby S Van Voorhees; Christoph T Ellebrecht; Justine Fenner; Anthony Ocon; Maha N Syed; Erica J Weinstein; Jessica Smith; George Gondo; Sue Heydon; Samantha Koons; Christopher T Ritchlin
Journal:  J Am Acad Dermatol       Date:  2020-09-04       Impact factor: 15.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.